Surgepays is trading at $0.12, down 5.83%, and the reason for the October 19 decline remains unclear. - No fresh company-specific announcement explaining the move appeared in the news checked; the latest identified release was the October 15 GrowthLine announcement. - Reuters reported broader U.S. stocks were higher on October 19, so available evidence does not point to a matching market-wide decline.